The report will be delivered in 2-3 business days.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Global Report 2020-30: Covid 19 Impact and Recovery

Starting Price : $ 4000.00 | Pages : 150 | Published : April 2020 | SKU CODE : 7639 | Format :


The pharmaceutical contract development and manufacturing market consists of sales of pharmaceutical contract development and manufacturing products and related services. Some pharmaceutical companies outsource the manufacturing of products on contracts to focus on the R&D, marketing and branding of their products. The pharmaceutical contract development and manufacturing market consists of manufacturing firms who manufacture drugs and other pharmaceutical products for other pharmaceutical companies on contractual basis.

The global pharmaceutical contract development and manufacturing market is expected to decline from $99.8 billion in 2019 to $93 billion in 2020 at a compound annual growth rate (CAGR) of -7%. The decline is mainly due to the focus on Covid-19 outbreak and its treatment across the globe, and disruption in the supply chain owing to geographical trade barriers affecting the supply of APIs and raw materials for drug manufacturing. Sponsors contracting CMOs are pausing the drug development activities due to Covid19 or restructuring the current drug development plans. The market is then expected to recover and reach $128.4 billion in 2023 at a CAGR of 6.5%.

The pharmaceutical contract manufacturing organization market (CMO) market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019.

The pharmaceutical contract development and manufacturing market covered in this report is segmented by type into active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development & manufacturing and secondary packaging.

The growth of the pharmaceutical contract development and manufacturing market is driven by the increase in the demand for medicines across the globe. The high prevalence of diseases and the need for a longer lifespan increased the demand for medicines pushing the pharmaceutical companies to increase the production of existing drugs and rise the investment in their R&D to promote the development of new drugs. This impels the pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to lower operational costs, thus, increasing the demand in pharmaceutical contract development and manufacturing market. For instance, as reported by PutmanMedia, a USA based online media firm, in 2018, 51% of the total New Molecular Entities (NMEs) approved by the US Food and Drug Administration were outsourced to contract manufacturers whereas a total amount of $86 billion was given to the contracted services for R&D. The rising need for medicines is thereby boosting the growth of the pharmaceutical contract development and manufacturing market.

The pharmaceutical contract development and manufacturing market is restricted by the poor-capacity utilization of manufacturing facilities. The capacity utilization is calculated considering the full potential capacity of the production plant. The poor-capacity utilization of the production plant is caused due to the inefficiency of different sub-processes in the production line which results in low production. The low production output results in low revenue generation for the production unit, affecting the overall pharmaceutical contract development and manufacturing market. For instance, according to an article by the Trade Promotion Council of India (TPCI) most of the pharmaceutical production units in India run at 30-40% of their capacity. Therefore, the under usage of capacity of production plant negatively affects the pharmaceutical contract development and manufacturing market.

The companies in the pharmaceutical contract development and manufacturing market are investing towards acquiring and forming alliances with other companies in the market. The pharmaceutical contract development and manufacturing companies are following the trend of merger and acquisition in order to expand their global market reach to meet the client needs, to increase their production capabilities while maintaining cost efficiencies and to get access to latest technology and new services. The high level of merger and acquisition activities are resulting in consolidation of the contract service providers. For instance, according to Zymewire, a Canada based digital sales research assistant, the number of total acquisitions of pharmaceutical contract development and manufacturing companies was 130 for the period from 2015-2017 with 70% of the companies acquiring were operating companies and remaining 30% of company acquisitions were by public equity firms.

In 2019, Permira Funds, a European equity firm acquired Cambrex Corporation for $2.4 billion. The acquisition is aimed to strengthen and expand the products and services offered by Cambrex Corporation towards the manufacturing of drugs. The Cambrex Corporation is a USA based contract development and manufacturing (CDMO) firm involved with the products and services related to small molecule active pharmaceutical ingredients.

Major players in the market are Recipharm AB, Pfizer Inc., Boehringer Ingelheim International GmbH., Aenova Group, Famar, Jubilant Life Sciences Limited, Catalent Pharma Solutions, Chemicals Limited, Dishman Pharmaceuticals and HAUPT Pharma AG.

The companies covered are Recipharm AB; Pfizer Inc.; Boehringer Ingelheim International GmbH.; Aenova Group; Famar; Jubilant Life Sciences Limited,; Catalent Pharma Solutions; Chemicals Limited; Dishman Pharmaceuticals ; HAUPT Pharma AG; Kemwell Pvt. Ltd.; Nipro Corp.; NextPharma; Royal DSM N.V; Althea Technologies; Thermo Fisher Scientific Inc. ; Lonza Group Ltd; AbbVie Inc.; Consort Medical plc ; Almac Group; Siegfried Holding AG ; Evonik Industries AG; Vetter Pharma International GMBH

Countries covered are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing; Finished Dosage Formulation (FDF) Development & Manufacturing; Secondary Packaging

    1. Executive Summary

    2. Pharmaceutical Contract Development And Manufacturing Market Characteristics

    3. Pharmaceutical Contract Development And Manufacturing Market Size And Growth

    3.1. Global Pharmaceutical Contract Development And Manufacturing Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Pharmaceutical Contract Development And Manufacturing Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Pharmaceutical Contract Development And Manufacturing Market Segmentation

    4.1. Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Active Pharmaceutical Ingredient (API) Manufacturing

    Finished Dosage Formulation (FDF) Development & Manufacturing

    Secondary Packaging

    5. Pharmaceutical Contract Development And Manufacturing Market Regional And Country Analysis

    5.1. Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market  

    6.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Overview  

    6.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Pharmaceutical Contract Development And Manufacturing Market  

    7.1. China Pharmaceutical Contract Development And Manufacturing Market Overview  

    7.2. China Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Pharmaceutical Contract Development And Manufacturing Market  

    8.1. India Pharmaceutical Contract Development And Manufacturing Market Overview  

    8.2. India Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Pharmaceutical Contract Development And Manufacturing Market  

    9.1. Japan Pharmaceutical Contract Development And Manufacturing Market Overview  

    9.2. Japan Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Pharmaceutical Contract Development And Manufacturing Market  

    10.1. Australia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Pharmaceutical Contract Development And Manufacturing Market  

    11.1. Indonesia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Pharmaceutical Contract Development And Manufacturing Market  

    12.1. South Korea Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Pharmaceutical Contract Development And Manufacturing Market  

    13.1. Western Europe Pharmaceutical Contract Development And Manufacturing Market Overview

    13.2. Western Europe Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Pharmaceutical Contract Development And Manufacturing Market  

    14.1. UK Pharmaceutical Contract Development And Manufacturing Market Overview

    14.2. UK Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Pharmaceutical Contract Development And Manufacturing Market  

    15.1. Germany Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Pharmaceutical Contract Development And Manufacturing Market  

    16.3. France Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market  

    17.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market Overview

    17.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Pharmaceutical Contract Development And Manufacturing Market  

    18.1. Russia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Pharmaceutical Contract Development And Manufacturing Market  

    19.1. North America Pharmaceutical Contract Development And Manufacturing Market Overview

    19.2. North America Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Pharmaceutical Contract Development And Manufacturing Market  

    20.1. USA Pharmaceutical Contract Development And Manufacturing Market Overview

    20.2. USA Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Pharmaceutical Contract Development And Manufacturing Market  

    21.1. South America Pharmaceutical Contract Development And Manufacturing Market Overview

    21.2. South America Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Pharmaceutical Contract Development And Manufacturing Market  

    22.1. Brazil Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Pharmaceutical Contract Development And Manufacturing Market  

    23.1. Middle East Pharmaceutical Contract Development And Manufacturing Market Overview

    23.2. Middle East Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Pharmaceutical Contract Development And Manufacturing Market  

    24.1. Africa Pharmaceutical Contract Development And Manufacturing Market Overview

    24.2. Africa Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Pharmaceutical Contract Development And Manufacturing Market Competitive Landscape And Company Profiles

    25.1. Pharmaceutical Contract Development And Manufacturing Market Competitive Landscape

    25.2. Pharmaceutical Contract Development And Manufacturing Market Company Profiles

    25.2.1. Recipharm AB

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Pfizer Inc.

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Catalent Pharma Solutions

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Aenova Group

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Famar

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Market

    27. Pharmaceutical Contract Development And Manufacturing Market Trends And Strategies

    28. Pharmaceutical Contract Development And Manufacturing Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: China, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: India, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Japan, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Australia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Indonesia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: South Korea, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: Western Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: UK, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Germany, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: France, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Russia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: North America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: USA, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: South America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Brazil, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Middle East, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Africa, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Recipharm AB Financial Performance
  • Table 26: Pfizer Inc. Financial Performance
  • Table 27: Catalent Pharma Solutions Financial Performance
  • Table 28: Aenova Group Financial Performance
  • Table 29: Famar Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: China, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: India, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Japan, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Australia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Indonesia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: South Korea, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: Western Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: UK, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Germany, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: France, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Russia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: North America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: USA, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: South America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Brazil, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Middle East, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Africa, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Recipharm AB Financial Performance
  • Figure 26: Pfizer Inc. Financial Performance
  • Figure 27: Catalent Pharma Solutions Financial Performance
  • Figure 28: Aenova Group Financial Performance
  • Figure 29: Famar Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And By Regional Analysis | Global Forecast To 2023
View Report
Personal Care Services Market Research Report - By Type (Beauty Salons, Spas & Massage, Diet And Weight Reducing Centers, Other Personal Care Services), By End User Location (On Premise, Off Premise), By Age ( Below 15, 15-40, 40-65, Above 65), By Gender (Female, Male) And By Regions | Global Market Opportunities And Strategies To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous dry eye syndrome, Evaporative dry eye syndrome), By End-user (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment) And By Regional Analysis | Global Forecast To 2023
View Report
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2021
View Report
Genito-Urinary Drugs Market Global Briefing 2018
View Report
Musculoskeletal Drugs Market Global Briefing 2018
View Report
Oncology Drugs Market Global Briefing 2018
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)